Skip to main content

Colgate-Palmolive Company (CL-N) Quote - Press Release

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

More stories below advertisement

Colgate-Palmoliv (CL) Crosses Pivot Point Resistance at $70.31

Comtex SmarTrend(R) - Wed Sep 18, 9:23AM CDT

Colgate-Palmoliv (NYSE:CL) has opened bullishly above the pivot of $70.00 today and has reached the first level of resistance at $70.31. Investors may be interested in a cross of the next upside pivot targets of $70.76 and $71.52.

Over the past year, Colgate-Palmoliv has traded in a range of $57.41 to $76.41 and is now at $70.12, 22% above that low. The 200-day and 50-day moving averages have moved 0.36% higher and 0.04% lower over the past week, respectively.

Colgate-Palmoliv has overhead space with shares priced $70.12, or 2.5% below the average consensus analyst price target of $71.95. The stock should hit resistance at its 50-day moving average (MA) of $72.73, as well as support at its 200-day MA of $68.51.

SmarTrend is monitoring the recent change of momentum in Colgate-Palmoliv. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Colgate-Palmoliv in search of a potential trend change.

Write to SmarTrend at cs@mysmartrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).